B-cell Tumors

2

Review clinical trials related to B-cell Tumors. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Long-term Observational Study of Patients Treated With Inaticabtagene Autoleucel Injection

This clinical trial adopts an observational research method to conduct annual follow-up and monitoring of patients receiving treatment with Inaticabtagene Autoleucel Injection after its commercialization, in order to evaluate the delayed adverse events of Inaticabtagene Autoleucel Injection.

Participants needed: 1,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Juventas Cell Therapy Ltd.Updated: Aug 7, 2025Locations: 1
Eligibility criteria

Agree to sign an informed consent form for long-term follow-up studies. [+1]

Status: Not yet recruiting

JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases

JWCAR201 is a CD19/CD20 CAR-T product. This trial is intended to evaluate the safety, PK/PD and efficacy of JWCAR201 in patients with B cell driven hematology malignancy and autoimmune diseases

Participants needed: 15
Trial details
Phase: Phase 1Age: 18-70Biological sex: AllType: InterventionalSponsor: RenJi HospitalUpdated: Aug 22, 2024Locations: 1
Eligibility criteria

aged >= 18 years [+11]

Hepatitis B surface antigen (HBsAg) positivity (regardless of whether or not the... [+7]